FitLife Brands, Inc. (FTLF) stock
FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/3016% above fair value
$8.30−0.02 (-0.24%)
Close on Nov 12, 2026Market cap $77.95MP/E 43.7Yield –
FitLife Brands ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
FitLife Brands's ebitda for the twelve months ending Jun 30, 2026 was $4.38M. For fiscal 2025 it was $2.98M, down 77.5% from the year before. The highest annual figure on record is $13.23M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.98M | -77.5% |
| FY2024 | Dec 31, 2024 | $13.23M | +73.0% |
| FY2023 | Dec 31, 2023 | $7.64M | +32.5% |
| FY2022 | Dec 31, 2022 | $5.77M | -8.3% |
| FY2021 | Dec 31, 2021 | $6.29M | +43.5% |
| FY2020 | Dec 31, 2020 | $4.38M | +72.3% |
| FY2019 | Dec 31, 2019 | $2.55M | +252.5% |
| FY2018 | Dec 31, 2018 | $722.00K | – |
| FY2017 | Dec 31, 2017 | -$8.54M | -1716.5% |
| FY2016 | Dec 31, 2016 | $528.50K | – |
| FY2015 | Dec 31, 2015 | -$1.06M | -157.0% |
| FY2014 | Dec 31, 2014 | $1.86M | +32.7% |
| FY2013 | Dec 31, 2013 | $1.40M | -26.5% |
| FY2012 | Dec 31, 2012 | $1.91M | +304.0% |
| FY2011 | Dec 31, 2011 | $471.72K | – |
| FY2010 | Dec 31, 2010 | -$2.83M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.61M | +24.2% |
| Q1 FY2026 | Mar 31, 2026 | $3.31M | +3.3% |
| Q4 FY2025 | Dec 31, 2025 | -$4.99M | -234.7% |
| Q3 FY2025 | Sep 30, 2025 | $2.45M | -28.2% |
| Q4 FY2024 | Dec 31, 2024 | $2.90M | +56.8% |
| Q3 FY2024 | Sep 30, 2024 | $3.20M | +28.6% |
| Q2 FY2024 | Jun 30, 2024 | $3.70M | +42.0% |
| Q1 FY2024 | Mar 31, 2024 | $3.42M | +393.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.85M | +145.3% |
| Q3 FY2023 | Sep 30, 2023 | $2.49M | +59.9% |
| Q2 FY2023 | Jun 30, 2023 | $2.61M | +41.5% |
| Q1 FY2023 | Mar 31, 2023 | $692.00K | -57.0% |
| Q4 FY2022 | Dec 31, 2022 | $755.00K | -50.4% |
| Q3 FY2022 | Sep 30, 2022 | $1.56M | +7.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.84M | -10.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.61M | +26.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.52M | +3.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.45M | +3.2% |
| Q2 FY2021 | Jun 30, 2021 | $2.05M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.27M | -15.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.47M | +1024.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.40M | +27.8% |
| Q2 FY2020 | Jun 30, 2020 | $0 | -100.0% |
| Q1 FY2020 | Mar 31, 2020 | $1.51M | +44.3% |
| Q4 FY2019 | Dec 31, 2019 | $131.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $1.10M | +161.0% |
| Q2 FY2019 | Jun 30, 2019 | $271.00K | +16.8% |
| Q1 FY2019 | Mar 31, 2019 | $1.04M | +336.8% |
| Q4 FY2018 | Dec 31, 2018 | -$189.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $421.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $232.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $239.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.57M | – |
| Q3 FY2017 | Sep 30, 2017 | -$384.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$400.00K | -129.8% |
| Q1 FY2017 | Mar 31, 2017 | -$186.89K | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.63M | – |
| Q3 FY2016 | Sep 30, 2016 | -$232.70K | – |
| Q2 FY2016 | Jun 30, 2016 | $1.34M | – |
See a number that looks wrong?